AzTrials
AzTrials

Autism Spectrum DisorderVDTNCT06522490

Effects of Virtual Discrete Trial Training on Children With Autism Spectrum Disorder

A study testing Virtual discrete trial training in people with Autism Spectrum Disorder, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder categorized by deficits in social communication and the occurrence of restricted interests and repetitive behaviors. Read more about this study

Who is it for?
Ages 3 to 10 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Virtual discrete trial training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 sitePakistan
Study dates
2 Nov 2023to 1 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age range between 3-10 years.
  • Clinically diagnosed children from Psychologists were taken for study who had 2-3 words in vocabulary or no vocabulary at all.
  • Each group received 3 weekly sessions for 45 minutes for 12 weeks.
  • Video training was given through animated videos.

Who cannot join

  • Children with any comorbidities e.g. Intellectual Disability, Cerebral Palsy, Attention Deficit Hyperactive Disorder, Down's Syndrome and Hearing Impaired children will exclude from this study.
  • Children diagnosed with severe autism.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Pakistan society for rehabilitation of differently abled

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Autism spectrum disorder (ASD) is a neurodevelopmental disorder categorized by deficits in social communication and the occurrence of restricted interests and repetitive behaviors. The cautionary needs of children with ASD are significant, it affects parents and siblings as well and requires substantial social support. If adequate intervention is not provided to children with ASD on time, then they may face many difficulties for example in academic work. They face social isolation and may develop additional challenging behaviors. Applied behavior analysis (ABA) is one of the most commonly used supported treatments for autism spectrum disorder. Discrete Trial Training (DTT) is one of the most structured Applied Behavior Analysis (ABA) types. DTT is the best standardized therapy for ASD. The ABA explores human interactions with their environment over time and develops interventional strategies to diminish the decline in the troublesomeness of social behavior among individuals with ASD. DTT through video training Program will be an effective in improving the communication skills of children with ASD. The video training program offers excellent accessibility and is inexpensive because it can be administered remotely and at home as well. It also reduces the resource barrios.

A randomized controlled study was conducted on children aged between 3-10 years diagnosed with ASD at PSRD hospital having Different severity levels. DTT was provided through a video training program using digital technology with informed consent from their caregivers/parents. The sample size was 10. Both groups contain 5 participants. The treatment group will be trained on DTT through the video training program. Sessions were conducted thrice a week for 45 minutes. The duration of the experiment was 12 weeks. The control group did not intervene with the video training program during the experiment. Pre \& Post language assessment was done through British Picture Vocabulary Scale.

Being tested
Virtual discrete trial training
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual discrete trial trainingOther

    Also called Face to face therapy

    VDT was given to Experimental group.

Study groups in NCT06522490
Study groupRoleWhat they receive
Experimental groupExperimentalVideo Training was used for the experimental group
Receives: Other: Virtual discrete trial training
Controlled groupActive comparatorFace to face therapy was used for the control group
Receives: Other: Virtual discrete trial training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. British Picture Vocabulary Scale

    It helps you identify any delay in vocabulary development, even before children are in full-time education. BPVS3 is a one-to-one test in a simple and easy to administer format. For each question, you say a word and the pupil responds by selecting a picture from four options that best illustrates that word's meaning

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2024
  2. Study start2 Nov 2023
  3. Primary completion5 Jan 2024
  4. Study completion1 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06522490
Sponsor's protocol ID
RiphahIU-123 Shahzadi Arshad
Acronym
VDT
Status last verified
Jul 2024
First submitted
22 Jul 2024
Last updated
26 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual discrete trial training in people with Autism Spectrum Disorder, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

British Picture Vocabulary Scale (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in